AbCellera Expands Multi-Target Antibody Discovery Collaboration with Regeneron
VANCOUVER, BC –(BUSINESS WIRE)– AbCellera (Nasdaq: ABCL) announced today that it has expanded its existing multi-target collaboration with Regeneron (Nasdaq: REGN) to discover therapeutic antibodies for up to eight targets selected… Read More




